Ras p21 in breast tissue: associations with pathology and cellular localisation
- PMID: 1733441
- PMCID: PMC1977366
- DOI: 10.1038/bjc.1992.9
Ras p21 in breast tissue: associations with pathology and cellular localisation
Abstract
Immunocytochemistry with monoclonal antibody Y13-259 demonstrated p21 ras in paraffin sections of breast tissue from 171 women: 85 with invasive breast carcinoma, 14 with non-invasive carcinoma and 72 with benign changes only. Many different tissue elements contributed to ras expression. Semiquantitative assessment showed that intensity of immunostaining in the normal epithelium of large ducts, small extralobular ducts and terminal duct lobular units (TDLU) was usually exceeded by that of myoepithelial cells. Vascular smooth muscle and apocrine epithelium also stained strongly, but the flat epithelial cells lining cysts did not express detectable p21 ras. There was a progressive increase from normal epithelium through epithelial hyperplasia of usual type and atypical hyperplasia to carcinoma in situ, without further increase in invasive carcinoma. Expression in carcinomas was inversely related to oestrogen receptor content but independent of the prognosis-associated variables of size, histological type, vascular invasion or lymph node metastasis.
Similar articles
-
Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues.Cancer Res. 1986 May;46(5):2511-9. Cancer Res. 1986. PMID: 3084069
-
Immunohistochemical detection of ras p21 oncoprotein in breast cancer imprints.Acta Cytol. 1994 May-Jun;38(3):335-40. Acta Cytol. 1994. PMID: 8191822
-
Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.Anticancer Res. 1991 Jul-Aug;11(4):1485-94. Anticancer Res. 1991. PMID: 1660689
-
Use of immunohistochemistry in the diagnosis of problematic breast lesions.J Clin Pathol. 2013 Jun;66(6):471-7. doi: 10.1136/jclinpath-2012-201109. Epub 2013 Mar 13. J Clin Pathol. 2013. PMID: 23486609 Review.
-
[Diagnostic immunohistochemistry of breast epithelial lesions].Ann Pathol. 2003 Dec;23(6):570-81. Ann Pathol. 2003. PMID: 15094595 Review. French.
Cited by
-
Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy.Br J Cancer. 1995 Nov;72(5):1259-66. doi: 10.1038/bjc.1995.497. Br J Cancer. 1995. PMID: 7577479 Free PMC article.
-
Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer.Breast Cancer (Auckl). 2016 Aug 17;10:109-46. doi: 10.4137/BCBCR.S39384. eCollection 2016. Breast Cancer (Auckl). 2016. PMID: 27559297 Free PMC article. Review.
-
Xiaozheng pill exerts an anti-mammary hyperplasia effect through Raf/ERK/ELK and HIF-1α/bFGF pathways.J Tradit Complement Med. 2023 Jun 7;13(6):600-610. doi: 10.1016/j.jtcme.2023.05.002. eCollection 2023 Nov. J Tradit Complement Med. 2023. PMID: 38020551 Free PMC article.
-
Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer.BMC Cancer. 2018 May 8;18(1):541. doi: 10.1186/s12885-018-4282-0. BMC Cancer. 2018. PMID: 29739347 Free PMC article.
-
Ras protein expression as a marker for breast cancer.Oncol Lett. 2016 Jun;11(6):3637-3642. doi: 10.3892/ol.2016.4461. Epub 2016 Apr 19. Oncol Lett. 2016. PMID: 27284366 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous